Eli Lilly LLY EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Eli Lilly’s reported figures.
The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eli Lilly's EBIT?
- Eli Lilly (LLY) reported EBIT of $8.85B in Q1 2026.
- How has Eli Lilly's EBIT changed year-over-year?
- Eli Lilly's EBIT increased by 156.1% year-over-year, from $3.46B to $8.85B.
- What is the long-term trend for Eli Lilly's EBIT?
- Over 4 years (2021 to 2025), Eli Lilly's EBIT has grown at a 43.0% compound annual growth rate (CAGR), from $6.16B to $25.73B.
- What does EBIT mean?
- Profit before interest and taxes — the business's core earning power.
- How do you interpret EBIT?
- Higher is better. Because it adds back interest, EBIT compares earning power across firms with very different debt loads — the base for interest coverage and the EV/EBIT multiple. For filers reporting operating income it equals that line, excluding non-operating swings.
- How does EBIT compare across companies?
- Comparable across companies regardless of leverage or tax domicile; the standard 'earning power' line for cross-company analysis. Least meaningful for banks and insurers.